# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 03-05-2019 | 01-31-2019 | 10-K | |
2 | 12-11-2018 | 10-31-2018 | 10-Q | |
3 | 09-13-2018 | 07-31-2018 | 10-Q | |
4 | 06-04-2018 | 04-30-2018 | 10-Q | |
5 | 04-30-2018 | 01-31-2018 | 10-K |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and lowers the price tar...
Roth MKM analyst Scott Fortune maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and lowers the price target from $...
Lake Street analyst Ben Klieve maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and lowers the price target from $...
Oppenheimer analyst Kristen Owen maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Outperform and lowers the price targ...
Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly sales of $124.000 which missed the analyst consensus estimate of $135....
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) announced today that the United States Department of Agriculture (USDA) has favorab...
- Reuters